These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24212106)

  • 21. The pharmaceutical industry and continuing education.
    Sarmiento A
    JAMA; 2001 Jul; 286(3):302; author reply 303-4. PubMed ID: 11466087
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmaceutical industry and continuing education.
    Cleophas TJ; Cleophas RC
    JAMA; 2001 Jul; 286(3):302-3; author reply 303-4. PubMed ID: 11466088
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmaceutical industry and continuing education.
    Madlon-Kay DJ
    JAMA; 2001 Jul; 286(3):303-4. PubMed ID: 11466089
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmaceutical industry and continuing education.
    Dermksian G
    JAMA; 2001 Jul; 286(3):302; author reply 303-4. PubMed ID: 11466086
    [No Abstract]   [Full Text] [Related]  

  • 25. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 27. Questionnaire survey on sponsorship of Continuing Medical Education program by pharmaceutical companies.
    Jain MM; Khatib SA; Shenoi A
    Indian Pediatr; 2000 Feb; 37(2):190-2. PubMed ID: 10745416
    [No Abstract]   [Full Text] [Related]  

  • 28. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 30. A historical perspective of pharmaceutical promotion and physician education.
    Podolsky SH; Greene JA
    JAMA; 2008 Aug; 300(7):831-3. PubMed ID: 18714063
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 33. The future sponsorship of CME in Canada: industry, government, physicians or a blend?
    Marlow B
    CMAJ; 2004 Jul; 171(2):150-1. PubMed ID: 15262885
    [No Abstract]   [Full Text] [Related]  

  • 34. Examining the value of commercially supported CME.
    Miller LA
    J Contin Educ Health Prof; 2009; 29(1):68-70. PubMed ID: 19288557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug makers battle a U.S. plan to curb rewards for doctors.
    Pear R
    N Y Times Web; 2002 Dec; ():A1, A28. PubMed ID: 12561833
    [No Abstract]   [Full Text] [Related]  

  • 36. Industry support of physician education in the USA.
    Fleischman W; Ross JS
    J Epidemiol Community Health; 2017 Mar; 71(3):213-216. PubMed ID: 27612981
    [No Abstract]   [Full Text] [Related]  

  • 37. Commercial sponsorship of CME: there are alternatives.
    Susman JL
    J Fam Pract; 2004 Sep; 53(9):676, 690. PubMed ID: 15353151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug indoctrination or education? You are member of the county council's political committee].
    Andrén-Sandberg A
    Lakartidningen; 2003 Oct; 100(42):3328-32. PubMed ID: 14619046
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuing education, industry, and physicians.
    DeMaria AN
    J Am Coll Cardiol; 2008 Sep; 52(12):1035-6. PubMed ID: 18786488
    [No Abstract]   [Full Text] [Related]  

  • 40. Financial relationships between medical communication companies and industry.
    Kopelow M
    JAMA; 2014 Apr 23-30; 311(16):1691-2. PubMed ID: 24756521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.